Teddi Mellencamp says she has 'multiple tumors': 'I will win this battle'
Teddi Mellencamp says she has "multiple tumors" after undergoing scans.
The former "Real Housewives of Beverly Hills" star shared an update on Instagram on Thursday and said that tumors were found in her brain and lungs.
"I have multiple tumors in my brain that weren't able to be removed via surgery. I also have 2 tumors in my lung. These are all metastases of my melanoma," she said.
Teddi Mellencamp's estranged husband shares update after her emergency brain surgery
"The doctors are hopeful that immunotherapy will effectively treat them," she added.
Mellencamp said she is "feeling positive" that she "will win this battle."
"Now a @bravoandy would say: with all due… f*** off, cancer!" she wrote.
The news comes nearly a month after the reality star revealed on Feb. 12 that she was diagnosed with a brain tumor. At the time, she said that doctors found "multiple tumors" in her brain after she had been suffering from what she described as "severe and debilitating" headaches.
She underwent surgery on the primary tumor site at the time and revealed that she would be moving on to treatment -- in a follow-up post on Feb. 28, Mellencamp stated that she was undergoing radiation -- after doctors found "more tumors than expected."
According to the American Cancer Society, melanoma is a "type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control."
'Real Housewives' star Teddi Mellencamp recovering after 'wide excision melanoma' surgery
"Melanoma is much less common than some other types of skin cancers. But melanoma is more dangerous because it's much more likely to spread to other parts of the body if not found and treated early," the American Cancer Society states.
On World Cancer Day in February, Mellencamp shared on the "Him & Her" podcast that he had undergone around 20 surgeries over the past three years as a result of her melanoma diagnosis.
Teddi Mellencamp says she has 'multiple tumors': 'I will win this battle' originally appeared on goodmorningamerica.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Testicular Cancer Epidemiology Review 2014-2024 and Forecast 2025-2034: US, UK, France, Italy, Spain, Germany, Japan, and India
In 2025, the American Cancer Society projects 9,729 new testicular cancer cases in the USA, with nearly 600 deaths. Most diagnoses occur at age 33. This report offers comprehensive analyses, treatment insights, and trends across eight key markets, including the US, UK, and Japan. Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Testicular Cancer Epidemiology Forecast 2025-2034" report has been added to to the American Cancer Society, approximately 9,729 new cases of testicular cancer are expected to be identified in The United States in 2025. Additionally, the disease is projected to cause nearly 600 deaths in the same year. The typical age at which individuals are diagnosed with testicular cancer is around 33 Cancer Epidemiology Forecast Report CoverageThe report delivers a comprehensive analysis of the condition's prevalence and associated demographic factors. It projects future incidence and prevalence trends across diverse population groups, considering key variables such as age, gender, and testicular cancer type. The report highlights changes in prevalence over time and offers data-driven forecasts based on influencing factors. Additionally, it provides an in-depth overview of the disease, along with historical and projected epidemiological data for eight key markets:The United States, United Kingdom, France, Italy, Spain, Germany, Japan, and OverviewThe epidemiology section on testicular cancer provides detailed insights into the patient population from historical data to present-day figures, along with forecasts across the eight major markets. The Research analyses multiple studies to outline both existing and anticipated trends. The report highlights diagnosed case numbers, segmented by factors such as age groups and patient demographics. According to the American Cancer Society, approximately 1 in 250 males will be diagnosed with testicular cancer in their lifetime. Research indicates the average age of diagnosis is 33, with 8% of cases found in men over 55 and 6% in children and teenagers. Cancer Research UK reported around 2,376 testicular cancer cases between 2017 and 2019 in the UK, with roughly 65 deaths. Among racial groups, white men in The United States show the highest incidence of the disease. Treatment Overview Treatment for testicular cancer typically involves a multidisciplinary approach, including surgery, chemotherapy, radiotherapy, and active surveillance depending on the cancer type and stage. The majority of patients are diagnosed early, leading to high survival rates. Seminomas and non-seminomas, the two main types of testicular cancer, respond well to treatment. Physicians determine treatment based on tumour markers, imaging results, and pathology. Advancements in targeted therapies and fertility preservation methods are improving outcomes and quality of life. Below are key treatment options commonly used for testicular cancer:1. OrchiectomyOrchiectomy is the primary surgical treatment for testicular cancer. It involves the removal of one or both testicles through an incision in the groin. This procedure is often the first step after diagnosis and provides tissue for further pathological analysis. Orchiectomy helps prevent cancer spread and is usually followed by additional therapies depending on the tumor stage and type. The surgery is typically straightforward and recovery time is short. Fertility and hormone levels can be affected, so patients may consider sperm banking and testosterone monitoring post-surgery.2. ChemotherapyChemotherapy uses powerful drugs to eliminate cancer cells, particularly in advanced or metastatic testicular cancer. It is especially effective for non-seminomatous germ cell tumors. Commonly used regimens include BEP (Bleomycin, Etoposide, and Cisplatin), usually administered over several cycles. Chemotherapy is often recommended after orchiectomy if cancer has spread to lymph nodes or distant organs. While highly effective, it can cause temporary side effects such as nausea, fatigue, hair loss, and increased infection risk. Long-term effects like infertility or cardiovascular issues are monitored in survivorship care plans.3. RadiotherapyRadiotherapy is most commonly used to treat seminomas, which are highly sensitive to radiation. It involves directing targeted radiation beams at lymph nodes, usually in the abdominal or pelvic region, to destroy residual cancer cells. This treatment is generally used after surgery if there's a high risk of recurrence. Radiotherapy is less frequently used for non-seminomas due to lower effectiveness. Side effects may include fatigue, skin irritation, and digestive issues. Advances in imaging and technology have improved the precision of radiation delivery, minimizing damage to healthy tissues.4. Retroperitoneal Lymph Node Dissection (RPLND)RPLND is a complex surgical procedure performed to remove lymph nodes in the abdomen where testicular cancer may spread, especially in cases involving non-seminomatous germ cell tumors. This procedure is often done after chemotherapy if residual masses remain or in early-stage cancer with a high risk of metastasis. RPLND requires expert surgical skill and may result in temporary digestive issues or loss of ejaculation due to nerve damage, though nerve-sparing techniques can help preserve function. It offers a potential cure when cancer is confined to the lymph nodes.5. Active SurveillanceActive surveillance is recommended for patients with early-stage testicular cancer, particularly those with low-risk seminomas or non-seminomas. This approach involves regular follow-ups, including physical exams, blood tests, and imaging, to monitor for recurrence without immediate treatment. It avoids overtreatment and preserves quality of life while maintaining high survival outcomes. If any signs of recurrence are detected, curative treatment is initiated promptly. This strategy is gaining popularity due to the excellent prognosis of testicular cancer and the desire to reduce long-term treatment-related side Epidemiology TrendsTesticular cancer continues to show distinctive epidemiological patterns that reflect both biological factors and evolving healthcare practices. While it remains a relatively rare form of cancer, accounting for a small percentage of male cancers globally, recent trends highlight significant developments in its incidence, demographics, risk patterns, and outcomes. These shifts are crucial for improving early detection strategies, tailoring public health initiatives, and optimizing treatment approaches.1. Rising Incidence in Developed RegionsOne of the most notable trends is the increasing incidence of testicular cancer in developed countries, particularly in Europe, North America, and Oceania. Although the underlying reasons are not fully understood, environmental and lifestyle factors, including exposure to endocrine-disrupting chemicals, delayed parenthood, and reduced physical activity, are believed to contribute. The increase is especially prominent among young and middle-aged men, which is prompting further investigation into genetic and environmental interactions. Improved diagnostic awareness and access to healthcare in these regions may also account for part of the rise.2. Age-Related Diagnosis PatternsTesticular cancer remains a disease that predominantly affects younger males, with the highest prevalence observed in individuals aged 15 to 40. However, recent years have shown subtle shifts in age-related diagnosis. While the median age remains consistent, there has been a gradual increase in cases among older men, particularly those over 55. This trend is drawing attention to the need for more inclusive awareness campaigns, which traditionally focus on younger populations. Age-specific changes in testicular function or prolonged exposure to risk factors might be contributing to these emerging patterns.3. Racial and Ethnic DisparitiesEpidemiological studies have shown that testicular cancer has higher incidence rates among Caucasian men compared to other racial or ethnic groups. However, recent data indicate a gradual narrowing of this gap, with incidence increasing among Hispanic and African American populations in some regions. This could reflect changes in environmental exposures or improvements in healthcare access and cancer reporting. These disparities underscore the importance of developing culturally relevant awareness and screening initiatives to ensure early diagnosis and effective treatment across all demographic groups.4. Improved Survival and Early DetectionSurvival rates for testicular cancer continue to improve, largely due to earlier detection and advances in treatment. Public awareness campaigns and the availability of high-quality diagnostic imaging have led to an increase in the detection of early-stage tumours. Consequently, more patients are receiving timely and effective interventions. The continued evolution of surgical techniques, chemotherapeutic regimens, and post-treatment surveillance strategies has significantly reduced mortality, especially in high-income nations. The focus now extends to survivorship care, including fertility preservation and management of long-term side effects.5. Increased Incidence of Germ Cell TumoursThere has been a documented rise in germ cell tumours, the most common histological subtype of testicular cancer. These tumours, which include both seminomas and non-seminomas, are believed to have origins in foetal development but typically manifest in adolescence or early adulthood. The increasing incidence suggests a complex interplay between genetic susceptibility and prenatal or early-life environmental factors. Research is ongoing to understand these triggers, and the trend reinforces the need for longitudinal studies and targeted preventive strategies focused on reproductive health and environmental risk By RegionThe epidemiology of testicular cancer varies across countries and regions due to differences in healthcare infrastructure, socioeconomic factors, cultural attitudes towards pain, and access to pain management therapies. Understanding these variations is essential for developing targeted interventions and improving patient regions include: The United States Germany France Italy Spain The United Kingdom Japan India These regions exhibit distinct epidemiological trends, reflecting the unique challenges and opportunities within their healthcare prevalence of testicular cancer differs notably across countries, influenced by genetic predispositions (including family history and conditions like cryptorchidism), lifestyle habits, dietary patterns, environmental influences, and disparities in healthcare access. In The United States, it is estimated that approximately 10,000 men are diagnosed with testicular cancer each Questions Answered What are the primary genetic and environmental risk factors associated with the incidence of testicular cancer across different populations? How does the age distribution of testicular cancer diagnoses vary across global regions? What trends have emerged over the past decade in testicular cancer incidence and mortality rates? How do racial and ethnic differences influence testicular cancer prevalence and survival outcomes? What role does early detection play in improving survival rates for testicular cancer patients? How has the prevalence of testicular cancer changed in high-income versus low-income countries? What is the impact of cryptorchidism on the lifetime risk of developing testicular cancer? How do lifestyle factors such as smoking, physical activity, or diet correlate with testicular cancer risk? What is the average latency period between exposure to risk factors and onset of testicular cancer symptoms? How accurate and complete are cancer registries in capturing the true burden of testicular cancer globally? Scope of the Report The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of testicular cancer based on several factors. The testicular cancer epidemiology forecast report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India) The report helps to identify the patient population, the unmet needs of testicular cancer are highlighted along with an assessment of the disease's risk and burden. Key Topics Covered1 Preface1.1 Introduction1.2 Objectives of the Study1.3 Research Methodology and Assumptions2 Executive Summary3 Testicular Cancer Market Overview - 8 MM3.1 Testicular Cancer Market Historical Value (2018-2024)3.2 Testicular Cancer Market Forecast Value (2025-2034)4 Testicular Cancer Epidemiology Overview - 8 MM4.1 Testicular Cancer Epidemiology Scenario (2018-2024)4.2 Testicular Cancer Epidemiology Forecast5 Disease Overview5.1 Signs and Symptoms5.2 Causes5.3 Risk Factors5.4 Guidelines and Stages5.5 Pathophysiology5.6 Screening and Diagnosis5.7 Types of Testicular Cancer6 Patient Profile6.1 Patient Profile Overview6.2 Patient Psychology and Emotional Impact Factors7 Epidemiology Scenario and Forecast - 8 MM7.1 Key Findings7.2 Assumptions and Rationale7.3 Testicular Cancer Epidemiology Scenario in 8MM (2018-2034)8 Epidemiology Scenario and Forecast: United States8.1 Testicular Cancer Epidemiology Scenario and Forecast in The United States (2018-2034)9 Epidemiology Scenario and Forecast: United Kingdom9.1 Testicular Cancer Epidemiology Scenario and Forecast in United Kingdom (2018-2034)10 Epidemiology Scenario and Forecast: Germany10.1 Testicular Cancer Epidemiology Scenario and Forecast in Germany (2018-2034)11 Epidemiology Scenario and Forecast: France11.1 Testicular Cancer Epidemiology Scenario and Forecast in France12 Epidemiology Scenario and Forecast: Italy12.1 Testicular Cancer Epidemiology Scenario and Forecast in Italy (2018-2034)13 Epidemiology Scenario and Forecast: Spain13.1 Testicular Cancer Epidemiology Scenario and Forecast in Spain (2018-2034)14 Epidemiology Scenario and Forecast: Japan14.1 Testicular Cancer Epidemiology Scenario and Forecast in Japan (2018-2034)15 Epidemiology Scenario and Forecast: India15.1 Testicular Cancer Epidemiology Scenario and Forecast in India (2018-2034)16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) InsightsFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Samantha Bowen shines on as a top health influencer
EAST PROVIDENCE, R.I. (WPRI) — Samantha Bowen, a local health influencer and marketing professional, appeared as a guest on Spotlight New England. Bowen, who runs a successful Instagram account called 'The Haute Health,' uses her platform to promote a well-rounded healthy lifestyle. In the video above, the East Providence native draws inspiration from her own health journey and showcases the exercises and self-care routines that work for her. Spotlight New England airs weekdays on the WPRI 12+ TV app and the and apps to get breaking news and weather alerts. Watch or with the new . Follow us on social media: Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
New York Post
8 hours ago
- New York Post
Concerned mom is ruffling feathers by urging parents to stop overscheduling kids: ‘This is crucial'
Parents, it's time to chill. A pediatric nurse practitioner is going viral for telling moms and dads to pump the brakes on ballet, soccer, piano and Kumon — because their kids are heading toward total burnout before they even hit first grade. Mary Catherine, aka @ on Instagram, is fed up with families turning into full-time Uber services, shuttling little ones from one extracurricular to the next with zero downtime in between. 'This might ruffle some feathers, but it's a hill I will die on as a pediatric nurse and mom to young kids… I firmly believe we are starting our kids in organized sports/ activities WAY TOO EARLY,' she wrote in a recent post. 'My daughter is in kindergarten and most of her classmates are involved in 2-3 after-school activities/ sports. That's A LOT.' Her prescription? Ditch the jam-packed schedules and give kids more time to just be kids. 3 One mom is slamming parents for acting like Uber drivers, hauling kids from one activity to the next with no breather in sight. liderina – 'Free play still needs to be prioritized in elementary age and younger kids. This is CRUCIAL,' she continued. Catherine swears by the 'one activity at a time' rule in her house for her two young kids — and experts say she's onto something. 'In my clinical experience, I've seen that children—especially those in early elementary years—who are consistently over-scheduled often present with signs of chronic distress,' Zishan Khan, MD, a psychiatric clinician, backed her up, telling Parents in a recent interview. Think: anxiety, trouble sleeping, mysterious stomachaches and enough sick days to rival flu season. 'The developing brain and body need downtime to process, grow and recover,' Khan added. 3 Catherine sticks to a strict 'one activity at a time' rule for her two tots — and the pros say she's not just winging it, she's right on the money. New Africa – Catherine emphasized the importance of letting kids engage in free play — the unfiltered, imaginative kind that doesn't require uniforms, scoreboards or permission slips. Khan agreed, calling free play 'critical' to childhood development. 'Through play, children learn to regulate their emotions, collaborate with others and develop a healthy sense of self,' he said. And while many parents might already be trying to squeeze in more free time for their kids, they still feel like it's not enough. As The Post previously reported, the average child already racks up 10 hours of play daily — split between parents, solo time and playing with friends or siblings — but three-quarters of parents say they still wish their child had more time for creative, unstructured play. 3 And while plenty of parents are trying to carve out more playtime, most still feel like it's a losing battle against the overbooked kid calendar. LIGHTFIELD STUDIOS – An overwhelming 92% of parents believe that kind of play is key to their child's growth and development — and they're not wrong. The top play activities? Physical games like dancing and ball tossing won out, followed by social play that involves sharing and teamwork. And while screen time is still part of the equation — kids clock about two hours a day on devices — most parents agree: off-screen play is crucial. Parents are also doing their part to keep curiosity alive. The same survey found they answer an average of 14 questions a day from their pint-sized philosophers — and many even study up to keep up. In the end, the experts and the data agree: When it comes to childhood, play isn't a luxury — it's essential.
